Adesh Kaul

Adesh Kaul serves as the Chief Financial Officer of Basilea Pharmaceutica, a Swiss biotech company specializing in therapies for hospital infections. Under his financial leadership, Basilea has seen significant revenue growth, reporting a total of 232 million Swiss francs in sales, with an expected increase to over 250 million in the coming year. Kaul emphasizes the company's commitment to investing a substantial portion of its revenue into research and development, which stands at 125 million francs, reflecting an ambitious strategy to expand its product portfolio in a competitive market.